Intravenous IV Solutions Market Report 2024 (Global Edition)

Global Intravenous IV Solutions Market Report 2024 Market Size Split by Nutrition Type (Total Parenteral Nutrition, Peripheral Parenteral Nutrition), by Nutritional Content (Amino Acid Solution, Carbo...

Intravenous IV Solutions Market Report Description

We have various report editions of Intravenous IV Solutions Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Intravenous IV Solutions Market Insights Video

Competitive Landscape of the Intravenous IV Solution Market

The intravenous (IV) answer market is relatively aggressive, offering key players, which include Baxter International, B. Braun Melsungen, Fresenius Kabi, and Hospira. These companies pay attention to innovation, product exceptional, and regulatory compliance to keep market share. Competitive strategies consist of mergers and acquisitions, partnerships, and increasing product portfolios to deal with diverse healthcare needs. Additionally, the market is characterized by a growing emphasis on sustainable practices and the improvement of superior IV solutions, which include pre-mixed and prepared-to-use formulations, to decorate patient protection and efficiency.

In September 2021, B. Braun Medical Inc. launched CARESAFE IV Administration Sets with an Optional AirStop component. Source: https://www.prnewswire.com/news-releases/b-braun-launches-caresafe-iv-administration-sets-with-optional-airstop-301380828.html

Top Companies Market Share in Intravenous IV Solutions Industry: (In no particular order of Rank)

• Ajinomoto Co.
• Inc.
• Amanta Healthcare
• Axa Parenterals Ltd
• B. Braun Melsungen AG
• Baxter International Inc.
• Fresenius Kabi USA
• LLC
• Grifols
• S.A.
• ICU Medical. Inc
• JW Life Science
• Otsuka Pharmaceutical Co.
• Ltd
• Pfizer
• Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Intravenous IV Solution Market

Which Region Dominates the Intravenous IV Solution Market in 2024?

According to Cognitive Market Research, North America currently dominates the Intravenous IV Total Parenteral Nutrition market, and the region is expected to have significant growth during the projected period. The North American intravenous (IV) solution marketplace is experiencing strong growth, pushed by the growing incidence of chronic illnesses, improvements in clinical strategies, and expanded healthcare expenditures. The demand for modern IV solutions, including pre-combined formulations, is similarly propelled by the focus on patient safety and advanced treatment consequences.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The Asia Pacific intravenous (IV) solution market is rapidly expanding due to growing healthcare demands, the increasing occurrence of chronic illnesses, and a growing aging population. Enhanced healthcare infrastructure and the adoption of superior scientific technology also stimulate marketplace growth, riding the demand for safe and effective IV solutions throughout the region.

The current report Scope analyzes Intravenous IV Solutions Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Intravenous IV Solutions

According to Cognitive Market Research, the global Intravenous IV Solution market size was estimated at USD 13524.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 5409.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 6.7% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Intravenous IV Solution market with a market size of USD 4268.33 million in 2024 and is projected to grow at a CAGR of 6.5% during the forecast period. The U.S. market's aging population.
• The Canada Intravenous IV Solution market had a market share of USD 649.18 million in 2024 and is projected to grow at a CAGR of 7.5% during the forecast period. Canada’s rising chronic diseases.
• The Mexico Intravenous IV Solution market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 492.29 million in 2024.

Europe Intravenous IV Solutions

According to Cognitive Market Research, the global Intravenous IV Solution market size was estimated at USD 13524.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 4057.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2031.

• The United Kingdom Intravenous IV Solution market had a market share of USD 681.63 million in 2024 and is projected to grow at a CAGR of 7.8% during the forecast period. In the UK, Intravenous IV Solution sales witness an upswing due to the hospitalization rates.
• The France Intravenous IV Solution market is projected to witness growth at a CAGR of 6.2% during the forecast period, with a market size of USD 373.28 million in 2024.
• According to Cognitive Market Research, the German Intravenous IV Solution market size was valued at USD 803.36 million in 2024 and is projected to grow at a CAGR of 7.2% during the forecast period. In Germany, Intravenous IV Solution surged due to the healthcare spending.
• The Italy Intravenous IV Solution market is projected to witness growth at a CAGR of 6.4% during the forecast period, with a market size of USD 348.93 million in 2024.
• The Russia Intravenous IV Solution market is projected to witness growth at a CAGR of 6.0% during the forecast period, with a market size of USD 628.89 million in 2024.
• The Spain Intravenous IV Solution market is projected to witness growth at a CAGR of 6.1% during the forecast period with a market size of USD 332.70 million in 2024
• The Luxembourg Intravenous IV Solution market is projected to witness growth at a CAGR of 7.1% during the forecast period, with a market size of USD 125.78 million in 2024.
• The Portugal Intravenous IV Solution market is projected to witness growth at a CAGR of 6.8% during the forecast period, with a market size of USD 85.20 million in 2024.
• The Greece Intravenous IV Solution market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 48.69 million in 2024.
• The Rest of Europe's Intravenous IV Solution market is projected to witness growth at a CAGR of 5.7% during the forecast period, with a market size of USD 628.89 million in 2024.

Asia Pacific Intravenous IV Solutions

According to Cognitive Market Research, the global Intravenous IV Solution market size was estimated at USD 13524.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 3110.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Intravenous IV Solution market size was valued at USD 1399.79 million in 2024 and is projected to grow at a CAGR of 10.0% during the forecast period. Intravenous IV Solution surged in China due to technological advancements.
• The Japan Intravenous IV Solution market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 429.27 million in 2024.
• The India Intravenous IV Solution market had a market share of USD 373.28 million in 2024 and is projected to grow at a CAGR of 12.3% during the forecast period. India's medical emergencies.
• The South Korean Intravenous IV Solution market is projected to witness growth at a CAGR of 9.6% during the forecast period, with a market size of USD 311.06 million in 2024.
• The Australian Intravenous IV Solution market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 161.75 million in 2024.
• The South East Asia Intravenous IV Solution market is projected to witness growth at a CAGR of 11.5% during the forecast period, with a market size of USD 214.63 million in 2024.
• The Rest of Asia Pacific Intravenous IV Solution market is projected to witness growth at a CAGR of 10.3% during the forecast period, with a market size of USD 220.86 million in 2024.

South America Intravenous IV Solutions

According to Cognitive Market Research, the global Intravenous IV Solution market size was estimated at USD 13524.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 676.23 million in 2024 and will grow at a compound annual growth rate (CAGR) of 7.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Intravenous IV Solution market size was valued at USD 289.42 million in 2024 and is projected to grow at a CAGR of 8.5% during the forecast period. Intravenous IV Total Parenteral Nutrition flourished in Brazil due to home healthcare.
• Argentina's Intravenous IV Solution market had a market share of USD 113.61 million in 2024 and is projected to grow at a CAGR of 8.8% during the forecast period. Argentina's R&D investments.
• Colombia Intravenous IV Solution market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 60.18 million in 2024.
• Peru Intravenous IV Solution market is projected to witness growth at a CAGR of 8.1% during the forecast period, with a market size of USD 55.45 million in 2024.
• Chile Intravenous IV Solution market is projected to witness growth at a CAGR of 8.2% during the forecast period, with a market size of USD 48.69 million in 2024.
• The Rest of Latin America's Intravenous IV Solution market is projected to witness growth at a CAGR of 7.0% during the forecast period, with a market size of USD 108.87 million in 2024.

Middle East and Africa Intravenous IV Solutions

According to Cognitive Market Research, the global Intravenous IV Solution market size was estimated at USD 13524.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 270.49 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2031..

• The GCC Countries Intravenous IV Solution market is projected to witness growth at a CAGR of 9.0% during the forecast period, with a market size of USD 115.77 million in 2024. Intravenous IV Solution sales flourish due to the government policies.
• The Egypt Intravenous IV Solution market is projected to witness growth at a CAGR of 8.5% during the forecast period, with a market size of USD 28.40 million in 2024.
• The South Africa Intravenous IV Solution market is projected to witness growth at a CAGR of 9.2% during the forecast period, with a market size of USD 42.74 million in 2024. Intravenous IV Solution sales flourished in South Africa due to increasing surgeries.
• The Turkey Intravenous IV Solution market is projected to witness growth at a CAGR of 7.7% during the forecast period, with a market size of USD 23.26 million in 2024.
• The Nigeria Intravenous IV Solution market is projected to witness growth at a CAGR of 7.3% during the forecast period, with a market size of USD 28.40 million in 2024.
• The Rest of the MEA Intravenous IV Solution market is projected to witness growth at a CAGR of 7.2% during the forecast period, with a market size of USD 31.92 million in 2024.

Intravenous IV Solutions Market Analysis

How are Segments Performing in the Global Intravenous IV Solution Market?

Intravenous IV Solution Market Nutrition Type Segment Analysis

According to Cognitive Market Research, Total Parenteral Nutrition are likely to dominate the Intravenous IV Solution Market over the forecast period. The demand for total parenteral nutrition (TPN) is contributing considerably to the increase in the intravenous (IV) solution market. TPN is vital for sufferers unable to achieve adequate vitamins through oral or enteral routes. Increased attention to dietary desires in scientific settings similarly boosts the adoption of TPN solutions in healthcare.

The Peripheral Parenteral Nutrition is the fastest-growing segment in the Intravenous IV Solution Market. The rising adoption of Peripheral Parenteral Nutrition (PPN) is driving an increase in the intravenous (IV) solution marketplace. PPN is critical for patients requiring quick-term dietary help, particularly people with restrained venous access. Increased awareness of its benefits in imparting crucial vitamins also propels its demand throughout healthcare settings.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Intravenous IV Solutions Industry. Request a Free Sample PDF!

Intravenous IV Solution Market Nutritional Content Segment Analysis

According to Cognitive Market Research, the Amino Acid Solution segment holds the largest share of the market. The growing usage of amino acid answers is boosting the intravenous (IV) solution market, as those answers play a crucial function in offering crucial vitamins for patients requiring parenteral vitamins. Their effectiveness in promoting healing, assisting metabolic features, and helping muscle renovation drives developing demand across diverse healthcare settings.

In the Intravenous IV Solution Market, the Carbohydrates has been expanding at a rapid pace. The demand for carbohydrate solutions in the intravenous (IV) solution marketplace is growing because of their role in presenting quick energy and retaining blood glucose levels for patients. These solutions are essential for those undergoing surgical treatment, trauma restoration, or in-depth care, as they improve the healing of the affected person and provide common metabolic assistance in clinical settings.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Intravenous IV Solutions End User Segment Analysis

Intravenous IV Solution Market End User Segment Analysis

According to Cognitive Market Research, Hospital & Clinics segment holds the largest market share. The intravenous (IV) solution marketplace is expanding in hospitals and clinics because of the growing patient population requiring medical interventions. Enhanced treatment protocols, which include the use of IV therapies for hydration, medication delivery, and nutrition guidance, are driving demand. Improved healthcare infrastructure, in addition, allows the adoption of IV solutions in those settings.

In the Intravenous IV Solution market, the rapidly growing sector is Ambulatory Surgical Centers. The intravenous (IV) solution market is experiencing an increase in ambulatory surgical facilities (ASCs) as those facilities increasingly perform minimally invasive procedures. The need for efficient hydration, medicine transport, and dietary guidance during outpatient surgeries drives demand for IV solutions, enhancing patient recuperation and usual remedy effectiveness in these settings.

• Hospital & Clinics
• Ambulatory Surgical Centers
• Home Care

Author's Detail

David Fuller

Senior Analyst at Cognitive Market Research

LinkedIn

Profile

I am working as a Senior Analyst with Cognitive Market Research in the areas of Industry Survey and Market Research/Analytics. I collaborate with CXOs, VPs, and other senior executives to understand their data needs and provide solutions and business strategy building.

Author's Conclusion